Looking really good at long last , can only see upside from Mayne's involvement with Novast to manufacture 13 oral contraceptives for the US . Mayne with its manufacturing plant that could be substantially larger if need be and Novast China with their know how and experience manufacturing / competing in international and highly competitive Drug industry plus Mithra involvement of course experienced well run with an excellent reputation in women's health products . These two companies can only be a real plus for Mayne now focused on the US market , manufacturing and presence in the States . IMHO
MYX Price at posting:
44.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)